1
项与 P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells(Lentigen) 相关的临床试验06-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients With MGMT Positive Tumors With Infusion of Autologous P140KMGMT+ Hematopoietic Progenitors to Protect Hematopoiesis
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. O6-benzylguanine may help temozolomide work better by making tumor cells more sensitive to the drug. Giving genetically modified peripheral blood stem cells during or after treatment may prevent side effects caused by chemotherapy.
PURPOSE: This clinical trial studies O6-benzylguanine and temozolomide in combination with genetically modified peripheral blood stem cells in treating patients with newly diagnosed glioblastoma multiforme.
100 项与 P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells(Lentigen) 相关的临床结果
100 项与 P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells(Lentigen) 相关的转化医学
100 项与 P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells(Lentigen) 相关的专利(医药)
100 项与 P140K methylguanine methyltransferase (MGMT) transduced human CD34 cells(Lentigen) 相关的药物交易